Comparison of volumetric modulated arc therapy and helical tomotherapy for prostate cancer using Pareto fronts.
Détails
Télécharger: 38055371.pdf (2152.67 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0
Etat: Public
Version: Final published version
Licence: CC BY 4.0
Document(s) secondaire(s)
Télécharger: paper_II_Appendix_A.pdf (814.73 [Ko])
Etat: Public
Version: Supplementary document
Licence: Non spécifiée
Etat: Public
Version: Supplementary document
Licence: Non spécifiée
Télécharger: paper_II_Appendix_B.pdf (132.87 [Ko])
Etat: Public
Version: Supplementary document
Licence: Non spécifiée
Etat: Public
Version: Supplementary document
Licence: Non spécifiée
Télécharger: paper_II_RATING_score_sheet.pdf (676.46 [Ko])
Etat: Public
Version: Supplementary document
Licence: Non spécifiée
Etat: Public
Version: Supplementary document
Licence: Non spécifiée
ID Serval
serval:BIB_49E1CA979679
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Comparison of volumetric modulated arc therapy and helical tomotherapy for prostate cancer using Pareto fronts.
Périodique
Medical physics
ISSN
2473-4209 (Electronic)
ISSN-L
0094-2405
Statut éditorial
Publié
Date de publication
04/2024
Peer-reviewed
Oui
Volume
51
Numéro
4
Pages
3010-3019
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Publication Status: ppublish
Résumé
Studies comparing different radiotherapy treatment techniques-such as volumetric modulated arc therapy (VMAT) and helical tomotherapy (HT)-typically compare one treatment plan per technique. Often, some dose metrics favor one plan and others favor the other, so the final plan decision involves subjective preferences. Pareto front comparisons provide a more objective framework for comparing different treatment techniques. A Pareto front is the set of all treatment plans where improvement in one criterion is possible only by worsening another criterion. However, different Pareto fronts can be obtained depending on the chosen machine settings.
To compare VMAT and HT using Pareto fronts and blind expert evaluation, to explain the observed differences, and to illustrate limitations of using Pareto fronts.
We generated Pareto fronts for twenty-four prostate cancer patients treated at our clinic for VMAT and HT techniques using an in-house script that controlled a commercial treatment planning system. We varied the PTV under-coverage (100% - V <sub>95%</sub> ) and the rectum mean dose, and fixed the mean doses to the bladder and femoral heads. In order to ensure a fair comparison, those fixed mean doses were the same for the two treatment techniques and the sets of objective functions were chosen so that the conformity indexes of the two treatment techniques were also the same. We used the same machine settings as are used in our clinic. Then, we compared the VMAT and HT Pareto fronts using a specific metric (clinical distance measure) and validated the comparison using a blinded expert evaluation of treatment plans on these fronts for all patients in the cohort. Furthermore, we investigated the observed differences between VMAT and HT and pointed out limitations of using Pareto fronts.
Both clinical distance and blind treatment plan comparison showed that VMAT Pareto fronts were better than HT fronts. VMAT fronts for 10 and 6 MV beam energy were almost identical. HT fronts improved with different machine settings, but were still inferior to VMAT fronts.
That VMAT Pareto fronts are better than HT fronts may be explained by the fact that the linear accelerator can rapidly vary the dose rate. This is an advantage in simple geometries that might vanish in more complex geometries. Furthermore, one should be cautious when speaking about Pareto optimal plans as the best possible plans, as their calculation depends on many parameters.
To compare VMAT and HT using Pareto fronts and blind expert evaluation, to explain the observed differences, and to illustrate limitations of using Pareto fronts.
We generated Pareto fronts for twenty-four prostate cancer patients treated at our clinic for VMAT and HT techniques using an in-house script that controlled a commercial treatment planning system. We varied the PTV under-coverage (100% - V <sub>95%</sub> ) and the rectum mean dose, and fixed the mean doses to the bladder and femoral heads. In order to ensure a fair comparison, those fixed mean doses were the same for the two treatment techniques and the sets of objective functions were chosen so that the conformity indexes of the two treatment techniques were also the same. We used the same machine settings as are used in our clinic. Then, we compared the VMAT and HT Pareto fronts using a specific metric (clinical distance measure) and validated the comparison using a blinded expert evaluation of treatment plans on these fronts for all patients in the cohort. Furthermore, we investigated the observed differences between VMAT and HT and pointed out limitations of using Pareto fronts.
Both clinical distance and blind treatment plan comparison showed that VMAT Pareto fronts were better than HT fronts. VMAT fronts for 10 and 6 MV beam energy were almost identical. HT fronts improved with different machine settings, but were still inferior to VMAT fronts.
That VMAT Pareto fronts are better than HT fronts may be explained by the fact that the linear accelerator can rapidly vary the dose rate. This is an advantage in simple geometries that might vanish in more complex geometries. Furthermore, one should be cautious when speaking about Pareto optimal plans as the best possible plans, as their calculation depends on many parameters.
Mots-clé
Male, Humans, Radiotherapy, Intensity-Modulated/methods, Radiotherapy Planning, Computer-Assisted/methods, Radiotherapy Dosage, Prostatic Neoplasms/radiotherapy, Rectum, Organs at Risk, helical tomotherapy (HT), multi‐criteria optimization (MCO), pareto front, prostate, volumetric modulated arc therapy (VMAT)
Pubmed
Web of science
Open Access
Oui
Création de la notice
07/12/2023 15:38
Dernière modification de la notice
09/04/2024 6:14